PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Over-the-counter sales of overdose reversal drug naloxone decline after initial surge

Price is a likely reason sales have been tepid

2025-09-15
(Press-News.org) Sales of the overdose reversal medication naloxone increased after it was made available to the public without a prescription but then dipped quickly in the period following debut of over-the-counter sales, according to a new RAND study.

 

Over-the-counter sales of naloxone peaked during the first month of availability in September 2023, then declined rapidly before stabilizing until August 2024, when there was a small increase, according to the study published in the journal JAMA Internal Medicine. The drug can prevent death among people who have overdosed on fentanyl or other opioids.

 

While a sales dropoff might be expected for a medication meant to be kept on hand until an emergency, even the peak levels of over-the-counter naloxone sales were only 7.5% as large as the quantity of naloxone sold by prescription.

 

“While the FDA’s approval of over-the-counter naloxone was intended to facilitate access to this life-saving medication, we found there was only limited uptake for over-the-counter sales,” said Bradley D. Stein, the study’s lead author and a senior physician policy researcher at RAND, a nonprofit research organization.

 

For the first time in many years, the number of Americans who died from opioid overdoses declined in 2023, attributed in part to the increased availability of naloxone.

 

Historically, Americans have obtained naloxone through prescription or free distribution programs. But in September 2023, naloxone became available over the counter with the hope it would increase access to the overdose reversal treatment.

 

Researchers analyzed sales information to calculate the county-level over-the-counter naloxone mean sales price and units sold per million county residents from September 2023 through the last week of September 2024.

 

They also reviewed pharmacy-dispensed naloxone rates from 2023, and program-distributed naloxone rates from August 2022 to August 2024.

 

There was considerable variation in the over-the-counter sales of naloxone across states, with Western states generally reporting higher sales. The national average was 396 over-the-counter units sold per million residents from September 2023 through September 2024. The average cost for a two-pack of naloxone nasal spray was nearly $45.   

 

The amount of naloxone distributed by pharmacies or free programs was much larger than over-the-counter sales. State-level pharmacy-dispensed units per million residents averaged 7,063 in 2023, while program-distributed naloxone averaged 12,015 units per million residents from August 2022 through August 2024.

 

Biweekly over-the-counter sales of naloxone peaked at approximately 22.5 units per million from Sept. 16 to Oct. 21, 2023, then declined to about 15 units per million in early December 2023. Sales remained between 11 to 15 units per million through September 2024, except for a brief increase in August 2024.

 

“It’s likely that the relatively high cost of over-the-counter naloxone has contributed to the limited sales,” Stein said. “That cost is likely going to limit over-the-counter sales of this important medication in the fight against the nation’s opioid crisis.”

 

Researchers say that additional research should examine factors potentially influencing demand for over-the-counter naloxone, such as possibly requiring health insurance coverage for over-the-counter sales and promoting visible placement in retail outlets.

 

Research reported in this press release was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number P50DA046351. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Other authors of the study are Rachel K. Landis, Rosanna Smart, Phoebe Levine, Abigail Kessler and Mark Sorbero, all of RAND, and Rosalie Liccardo Pacula of the University of Southern California.

 

RAND Health Care promotes healthier societies by improving health care systems in the United States and other countries.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Global trends and disparities in social isolation

2025-09-15
About The Study: In this cross-sectional study, social isolation was found to have increased globally after the COVID-19 pandemic, with the initial increase disproportionately seen in lower-income populations and subsequent increases broadening across socioeconomic strata. Targeted interventions for vulnerable groups and research examining country-level policies are urgently needed to mitigate high isolation levels and reduce inequities. Corresponding Author: To contact the corresponding author, Thomas E. Fuller-Rowell, PhD, email tef0005@auburn.edu. To ...

Country of birth, race, ethnicity, and prenatal depression

2025-09-15
About The Study: Across racial and ethnic groups, prenatal depression diagnosis and moderate to severe depression symptoms varied by maternal nativity in this cross-sectional study. The observed advantage among non–U.S.-born individuals across other maternal and neonatal outcomes may not uniformly apply to prenatal mental health conditions when race and ethnicity are considered. Future research should explore sociocultural factors that may influence this association. Corresponding Author: To contact the corresponding author, ...

Kissick Family Foundation, Milken Institute announce $2 million in funding for frontotemporal dementia research and new call for proposals

2025-09-15
September 15, 2025 (Washington, DC)—The Kissick Family Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), today announced that the Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program has awarded four two-year grants to basic and early-stage translational research teams to advance scientific understanding of the neurodegenerative disorder. These philanthropic grants total $2 million in new funding toward FTD research. The two partners have also announced the grant program’s third round of funding—now accepting ...

Mayo Clinic study reveals hidden causes of heart attacks in younger adults, especially women

2025-09-15
ROCHESTER, Minn. — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women — are caused by factors other than clogged arteries, challenging long-standing assumptions about how heart attacks occur in younger populations. Study findings published in the Journal of the American College of Cardiology examined over 15 years of data from the Rochester Epidemiology Project, providing the most comprehensive population evaluation of heart attack causes in people aged 65 and younger. More than half of heart attacks in women under age 65 were caused by nontraditional factors, such as spontaneous coronary ...

Target: BP initiative helps more than 10M adults with hypertension

2025-09-15
DALLAS, September 15, 2025 — Nearly half of U.S. adults — 122.4 million people — are living with high blood pressure (BP), a leading preventable risk factor for heart disease, stroke and premature death, according to the 2025 American Heart Association Statistical Update. Yet just a quarter of them have their BP under control, making both diagnosis and effective management critical. The American Heart Association, a relentless force changing the future of health for everyone everywhere, and American Medical Association (AMA) are recognizing 2,307 health care organizations — ...

New initiative launched to improve care for people with certain types of heart failure

2025-09-15
DALLAS, September 15, 2025 — The American Heart Association, a relentless force changing the future of health for everyone everywhere, is launching a new initiative to improve in-hospital care for people with heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF). HFpEF and HFmrEF collectively account for up to 75% of all heart failure cases, yet clinical research and treatment evidence in HFpEF and HFmrEF is substantially limited compared with other types of heart failure.[1],[2] The IMPLEMENT-EF quality improvement initiative will aim to address those challenges by mapping gaps in the patient ...

You’ve never seen corn like this before

2025-09-15
Plant stem cells are crucial for the world’s food supply, animal feed, and fuel production. They lay the foundation for how plants grow. Yet, much about these mysterious building blocks remains unknown. Previous analyses have failed to locate many of the important genes that regulate how these cells function. Now, for the first time, Cold Spring Harbor Laboratory (CSHL) plant biologists have mapped two known stem cell regulators across thousands of maize and Arabidopsis shoot cells. Their research also uncovered new stem cell regulators in both species and linked some to size variations in maize. This method for recovering rare stem cells could be used across the plant kingdom. ...

Mediterranean diet could reduce gum disease

2025-09-15
People living in the UK and following a diet close to the Mediterranean diet are more likely to have better gum health, with potentially lower amounts of gum disease and inflammation.  Findings from a King’s College London study indicate that people not following a Mediterranean – style diet tended to have more severe gum disease, especially if they consumed red meat frequently.   In these patients, the researchers observed higher levels of circulating inflammatory markers, such as Interleukin-6 (IL-6) and C-reactive protein (CRP).   However, patients whose diets were rich in plant-based food which ...

Mount Sinai launches cardiac catheterization artificial intelligence research lab

2025-09-15
Mount Sinai Fuster Heart Hospital has announced the launch of The Samuel Fineman Cardiac Catheterization Artificial Intelligence (AI) Research Lab. This new lab will leverage the hospital’s world-renowned Cardiac Catheterization Lab and its unrivaled expertise to advance the field of interventional cardiology and enhance patient care, patient outcomes, as well as to optimize complex treatment decisions.   Annapoorna Kini, MD, will serve as Director of The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab. As Director of The Mount Sinai Hospital’s Cardiac Catheterization ...

Why AI is never going to run the world

2025-09-15
COLUMBUS, Ohio – The secret to human intelligence can’t be replicated or improved on by artificial intelligence, according to researcher Angus Fletcher.   Fletcher, a professor of English at The Ohio State University’s Project Narrative, explains in a new book that AI is very good at one thing: logic. But many of life’s most fundamental problems require a different type of intelligence.   “AI takes one feature of intelligence – logic – and accelerates it. As long as life calls for math, AI crushes humans,” Fletcher writes in the book “Primal ...

LAST 30 PRESS RELEASES:

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

[Press-News.org] Over-the-counter sales of overdose reversal drug naloxone decline after initial surge
Price is a likely reason sales have been tepid